← 產業報告目錄
Hemocompatible Coatings Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-08-03頁數 127報告編號 APO-3ad9a074a5
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
Hemocompatible coatings constitute advanced interfacial modifications applied to the surfaces of blood-contacting medical devices to mitigate the risk of thrombosis and associated complications. These coatings function by attenuating the initial adsorption of plasma proteins, particularly fibrinogen and von Willebrand factor, thereby suppressing subsequent platelet adhesion, activation, and aggregation, as well as inhibiting activation of the intrinsic coagulation pathway. Effective hemocompatibility is achieved through precise control of surface chemistry and topography, addressing the fundamental challenge that virtually all synthetic biomaterials elicit a thrombogenic response upon blood exposure unless appropriately engineered.
Classification of hemocompatible coatings is based primarily on mechanism: active bioactive coatings versus passive bioinert coatings. Active coatings utilize covalently immobilized anticoagulants, with endpoint-attached heparin being the predominant example; the preserved antithrombin-binding pentasaccharide sequence catalyzes the inhibition of thrombin and factor Xa at the device surface without elution of the heparin molecule. Passive coatings rely on biomimetic or highly hydrophilic polymers, notably phosphorylcholine-based methacrylates, which replicate the zwitterionic character of the outer leaflet of endothelial cell membranes to form a stable hydration shell. This layer exerts steric repulsion and charge neutrality to minimize nonspecific protein fouling and cellular interactions independent of any pharmacological activity.
Deposition methods encompass covalent photoimmobilization, endpoint chemical coupling, plasma polymerization, and solution-based coating techniques, each optimized for substrate compatibility and mechanical durability under physiological shear stress. These technologies are integrated into a broad spectrum of devices, encompassing coronary and peripheral endovascular stents, ePTFE and polyester vascular grafts, indwelling catheters for central venous access and hemodialysis, extracorporeal membrane oxygenation circuits and cardiopulmonary bypass components, and rotary blood pumps in ventricular assist systems. Validation through ISO 10993-4 hemocompatibility testing protocols, complemented by ex vivo flow loop studies, large-animal implantation models, and clinical performance data from regulatory-approved devices, substantiates the reduction in thrombus formation and improvement in device patency and safety.
The global Hemocompatible Coatings market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Hemocompatible Coatings market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Hemocompatible Coatings market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Hemocompatible Coatings market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Hemocompatible Coatings include Surmodics, Carmeda AB, Coatings2Go, DSM Biomedical, Hydromer, AST Products, Smart Reactors, Alfa Chemistry and Biomerics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hemocompatible Coatings market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Hemocompatible Coatings.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hemocompatible Coatings Market by Company
Surmodics
Carmeda AB
Coatings2Go
DSM Biomedical
Hydromer
AST Products
Smart Reactors
Alfa Chemistry
Biomerics
Jiangsu Biosurf Biotech
Corline Biomedical
BioInteractions
Aurorium
Alta Biomed
jMedtech
Hemocompatible Coatings Segment by Type
Active (heparin)
Passive (non-heparin)
Hemocompatible Coatings Segment by Application
Interventional Catheters
ECMO & Extracorporeal
Stents & Vascular Grafts
Hemocompatible Coatings Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemocompatible Coatings market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemocompatible Coatings and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemocompatible Coatings.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Hemocompatible Coatings companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Hemocompatible Coatings by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Active (heparin)
2.2.3 Passive (non-heparin)
2.3 Hemocompatible Coatings by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Interventional Catheters
2.3.3 ECMO & Extracorporeal
2.3.4 Stents & Vascular Grafts
2.4 Assumptions and Limitations
3 Hemocompatible Coatings Breakdown Data by Type
3.1 Global Hemocompatible Coatings Historic Market Size by Type (2021-2026)
3.2 Global Hemocompatible Coatings Forecasted Market Size by Type (2027-2032)
4 Hemocompatible Coatings Breakdown Data by Application
4.1 Global Hemocompatible Coatings Historic Market Size by Application (2021-2026)
4.2 Global Hemocompatible Coatings Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Hemocompatible Coatings Market Perspective (2021-2032)
5.2 Global Hemocompatible Coatings Growth Trends by Region
5.2.1 Global Hemocompatible Coatings Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Hemocompatible Coatings Historic Market Size by Region (2021-2026)
5.2.3 Hemocompatible Coatings Forecasted Market Size by Region (2027-2032)
5.3 Hemocompatible Coatings Market Dynamics
5.3.1 Hemocompatible Coatings Industry Trends
5.3.2 Hemocompatible Coatings Market Drivers
5.3.3 Hemocompatible Coatings Market Challenges
5.3.4 Hemocompatible Coatings Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Hemocompatible Coatings Players by Revenue
6.1.1 Global Top Hemocompatible Coatings Players by Revenue (2021-2026)
6.1.2 Global Hemocompatible Coatings Revenue Market Share by Players (2021-2026)
6.2 Global Hemocompatible Coatings Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Hemocompatible Coatings Head Office and Area Served
6.4 Global Hemocompatible Coatings Players, Product Type & Application
6.5 Global Hemocompatible Coatings Manufacturers Established Date
6.6 Global Hemocompatible Coatings Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Hemocompatible Coatings Market Size (2021-2032)
7.2 North America Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Hemocompatible Coatings Market Size by Country (2021-2026)
7.4 North America Hemocompatible Coatings Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Hemocompatible Coatings Market Size (2021-2032)
8.2 Europe Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Hemocompatible Coatings Market Size by Country (2021-2026)
8.4 Europe Hemocompatible Coatings Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Hemocompatible Coatings Market Size (2021-2032)
9.2 Asia-Pacific Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Hemocompatible Coatings Market Size by Country (2021-2026)
9.4 Asia-Pacific Hemocompatible Coatings Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Hemocompatible Coatings Market Size (2021-2032)
10.2 South America Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Hemocompatible Coatings Market Size by Country (2021-2026)
10.4 South America Hemocompatible Coatings Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Hemocompatible Coatings Market Size (2021-2032)
11.2 Middle East & Africa Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Hemocompatible Coatings Market Size by Country (2021-2026)
11.4 Middle East & Africa Hemocompatible Coatings Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Surmodics
12.1.1 Surmodics Company Information
12.1.2 Surmodics Business Overview
12.1.3 Surmodics Revenue in Hemocompatible Coatings Business (2021-2026)
12.1.4 Surmodics Hemocompatible Coatings Product Portfolio
12.1.5 Surmodics Recent Developments
12.2 Carmeda AB
12.2.1 Carmeda AB Company Information
12.2.2 Carmeda AB Business Overview
12.2.3 Carmeda AB Revenue in Hemocompatible Coatings Business (2021-2026)
12.2.4 Carmeda AB Hemocompatible Coatings Product Portfolio
12.2.5 Carmeda AB Recent Developments
12.3 Coatings2Go
12.3.1 Coatings2Go Company Information
12.3.2 Coatings2Go Business Overview
12.3.3 Coatings2Go Revenue in Hemocompatible Coatings Business (2021-2026)
12.3.4 Coatings2Go Hemocompatible Coatings Product Portfolio
12.3.5 Coatings2Go Recent Developments
12.4 DSM Biomedical
12.4.1 DSM Biomedical Company Information
12.4.2 DSM Biomedical Business Overview
12.4.3 DSM Biomedical Revenue in Hemocompatible Coatings Business (2021-2026)
12.4.4 DSM Biomedical Hemocompatible Coatings Product Portfolio
12.4.5 DSM Biomedical Recent Developments
12.5 Hydromer
12.5.1 Hydromer Company Information
12.5.2 Hydromer Business Overview
12.5.3 Hydromer Revenue in Hemocompatible Coatings Business (2021-2026)
12.5.4 Hydromer Hemocompatible Coatings Product Portfolio
12.5.5 Hydromer Recent Developments
12.6 AST Products
12.6.1 AST Products Company Information
12.6.2 AST Products Business Overview
12.6.3 AST Products Revenue in Hemocompatible Coatings Business (2021-2026)
12.6.4 AST Products Hemocompatible Coatings Product Portfolio
12.6.5 AST Products Recent Developments
12.7 Smart Reactors
12.7.1 Smart Reactors Company Information
12.7.2 Smart Reactors Business Overview
12.7.3 Smart Reactors Revenue in Hemocompatible Coatings Business (2021-2026)
12.7.4 Smart Reactors Hemocompatible Coatings Product Portfolio
12.7.5 Smart Reactors Recent Developments
12.8 Alfa Chemistry
12.8.1 Alfa Chemistry Company Information
12.8.2 Alfa Chemistry Business Overview
12.8.3 Alfa Chemistry Revenue in Hemocompatible Coatings Business (2021-2026)
12.8.4 Alfa Chemistry Hemocompatible Coatings Product Portfolio
12.8.5 Alfa Chemistry Recent Developments
12.9 Biomerics
12.9.1 Biomerics Company Information
12.9.2 Biomerics Business Overview
12.9.3 Biomerics Revenue in Hemocompatible Coatings Business (2021-2026)
12.9.4 Biomerics Hemocompatible Coatings Product Portfolio
12.9.5 Biomerics Recent Developments
12.10 Jiangsu Biosurf Biotech
12.10.1 Jiangsu Biosurf Biotech Company Information
12.10.2 Jiangsu Biosurf Biotech Business Overview
12.10.3 Jiangsu Biosurf Biotech Revenue in Hemocompatible Coatings Business (2021-2026)
12.10.4 Jiangsu Biosurf Biotech Hemocompatible Coatings Product Portfolio
12.10.5 Jiangsu Biosurf Biotech Recent Developments
12.11 Corline Biomedical
12.11.1 Corline Biomedical Company Information
12.11.2 Corline Biomedical Business Overview
12.11.3 Corline Biomedical Revenue in Hemocompatible Coatings Business (2021-2026)
12.11.4 Corline Biomedical Hemocompatible Coatings Product Portfolio
12.11.5 Corline Biomedical Recent Developments
12.12 BioInteractions
12.12.1 BioInteractions Company Information
12.12.2 BioInteractions Business Overview
12.12.3 BioInteractions Revenue in Hemocompatible Coatings Business (2021-2026)
12.12.4 BioInteractions Hemocompatible Coatings Product Portfolio
12.12.5 BioInteractions Recent Developments
12.13 Aurorium
12.13.1 Aurorium Company Information
12.13.2 Aurorium Business Overview
12.13.3 Aurorium Revenue in Hemocompatible Coatings Business (2021-2026)
12.13.4 Aurorium Hemocompatible Coatings Product Portfolio
12.13.5 Aurorium Recent Developments
12.14 Alta Biomed
12.14.1 Alta Biomed Company Information
12.14.2 Alta Biomed Business Overview
12.14.3 Alta Biomed Revenue in Hemocompatible Coatings Business (2021-2026)
12.14.4 Alta Biomed Hemocompatible Coatings Product Portfolio
12.14.5 Alta Biomed Recent Developments
12.15 jMedtech
12.15.1 jMedtech Company Information
12.15.2 jMedtech Business Overview
12.15.3 jMedtech Revenue in Hemocompatible Coatings Business (2021-2026)
12.15.4 jMedtech Hemocompatible Coatings Product Portfolio
12.15.5 jMedtech Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Hemocompatible Coatings Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Hemocompatible Coatings Revenue Market Share by Type (2021-2026)
Table 7. Global Hemocompatible Coatings Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Hemocompatible Coatings Revenue Market Share by Type (2027-2032)
Table 9. Global Hemocompatible Coatings Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Hemocompatible Coatings Revenue Market Share by Application (2021-2026)
Table 11. Global Hemocompatible Coatings Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Hemocompatible Coatings Revenue Market Share by Application (2027-2032)
Table 13. Global Hemocompatible Coatings Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Hemocompatible Coatings Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Hemocompatible Coatings Market Share by Region (2021-2026)
Table 16. Global Hemocompatible Coatings Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Hemocompatible Coatings Market Share by Region (2027-2032)
Table 18. Hemocompatible Coatings Industry Trends
Table 19. Hemocompatible Coatings Industry Drivers
Table 20. Hemocompatible Coatings Industry Opportunities and Challenges
Table 21. Hemocompatible Coatings Market Restraints
Table 22. Global Top Hemocompatible Coatings Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Hemocompatible Coatings Revenue Market Share by Players (2021-2026)
Table 24. Global Hemocompatible Coatings Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Hemocompatible Coatings, Headquarters and Area Served
Table 26. Global Hemocompatible Coatings Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Hemocompatible Coatings by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Hemocompatible Coatings Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Hemocompatible Coatings Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Hemocompatible Coatings Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Hemocompatible Coatings Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Hemocompatible Coatings Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Hemocompatible Coatings Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Hemocompatible Coatings Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Hemocompatible Coatings Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Hemocompatible Coatings Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Hemocompatible Coatings Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Hemocompatible Coatings Market Size by Country (2027-2032) & (US$ Million)
Table 45. Surmodics Company Information
Table 46. Surmodics Business Overview
Table 47. Surmodics Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 48. Surmodics Hemocompatible Coatings Product Portfolio
Table 49. Surmodics Recent Developments
Table 50. Carmeda AB Company Information
Table 51. Carmeda AB Business Overview
Table 52. Carmeda AB Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 53. Carmeda AB Hemocompatible Coatings Product Portfolio
Table 54. Carmeda AB Recent Developments
Table 55. Coatings2Go Company Information
Table 56. Coatings2Go Business Overview
Table 57. Coatings2Go Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 58. Coatings2Go Hemocompatible Coatings Product Portfolio
Table 59. Coatings2Go Recent Developments
Table 60. DSM Biomedical Company Information
Table 61. DSM Biomedical Business Overview
Table 62. DSM Biomedical Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 63. DSM Biomedical Hemocompatible Coatings Product Portfolio
Table 64. DSM Biomedical Recent Developments
Table 65. Hydromer Company Information
Table 66. Hydromer Business Overview
Table 67. Hydromer Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 68. Hydromer Hemocompatible Coatings Product Portfolio
Table 69. Hydromer Recent Developments
Table 70. AST Products Company Information
Table 71. AST Products Business Overview
Table 72. AST Products Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 73. AST Products Hemocompatible Coatings Product Portfolio
Table 74. AST Products Recent Developments
Table 75. Smart Reactors Company Information
Table 76. Smart Reactors Business Overview
Table 77. Smart Reactors Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 78. Smart Reactors Hemocompatible Coatings Product Portfolio
Table 79. Smart Reactors Recent Developments
Table 80. Alfa Chemistry Company Information
Table 81. Alfa Chemistry Business Overview
Table 82. Alfa Chemistry Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 83. Alfa Chemistry Hemocompatible Coatings Product Portfolio
Table 84. Alfa Chemistry Recent Developments
Table 85. Biomerics Company Information
Table 86. Biomerics Business Overview
Table 87. Biomerics Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 88. Biomerics Hemocompatible Coatings Product Portfolio
Table 89. Biomerics Recent Developments
Table 90. Jiangsu Biosurf Biotech Company Information
Table 91. Jiangsu Biosurf Biotech Business Overview
Table 92. Jiangsu Biosurf Biotech Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 93. Jiangsu Biosurf Biotech Hemocompatible Coatings Product Portfolio
Table 94. Jiangsu Biosurf Biotech Recent Developments
Table 95. Corline Biomedical Company Information
Table 96. Corline Biomedical Business Overview
Table 97. Corline Biomedical Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 98. Corline Biomedical Hemocompatible Coatings Product Portfolio
Table 99. Corline Biomedical Recent Developments
Table 100. BioInteractions Company Information
Table 101. BioInteractions Business Overview
Table 102. BioInteractions Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 103. BioInteractions Hemocompatible Coatings Product Portfolio
Table 104. BioInteractions Recent Developments
Table 105. Aurorium Company Information
Table 106. Aurorium Business Overview
Table 107. Aurorium Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 108. Aurorium Hemocompatible Coatings Product Portfolio
Table 109. Aurorium Recent Developments
Table 110. Alta Biomed Company Information
Table 111. Alta Biomed Business Overview
Table 112. Alta Biomed Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 113. Alta Biomed Hemocompatible Coatings Product Portfolio
Table 114. Alta Biomed Recent Developments
Table 115. jMedtech Company Information
Table 116. jMedtech Business Overview
Table 117. jMedtech Revenue in Hemocompatible Coatings Business (2021-2026) & (US$ Million)
Table 118. jMedtech Hemocompatible Coatings Product Portfolio
Table 119. jMedtech Recent Developments
Table 120. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Hemocompatible Coatings Product Image
Figure 5. Global Hemocompatible Coatings Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Hemocompatible Coatings Market Share by Type: 2025 VS 2032
Figure 7. Active (heparin) Product
Figure 8. Passive (non-heparin) Product
Figure 9. Global Hemocompatible Coatings Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Hemocompatible Coatings Market Share by Application: 2025 VS 2032
Figure 11. Interventional Catheters Product
Figure 12. ECMO & Extracorporeal Product
Figure 13. Stents & Vascular Grafts Product
Figure 14. Global Hemocompatible Coatings Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 15. Global Hemocompatible Coatings Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 16. Global Hemocompatible Coatings Market Share by Region: 2025 VS 2032
Figure 17. Global Hemocompatible Coatings Market Share by Players in 2025
Figure 18. Global Hemocompatible Coatings Manufacturers Established Date
Figure 19. Global Top 5 and 10 Hemocompatible Coatings Players Market Share by Revenue in 2025
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 21. North America Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 22. North America Hemocompatible Coatings Market Share by Country (2021-2032)
Figure 23. United States Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. Canada Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Mexico Hemocompatible Coatings Market Share by Country (2021-2032)
Figure 26. Europe Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Europe Hemocompatible Coatings Market Share by Country (2021-2032)
Figure 28. Germany Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. France Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. U.K. Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Italy Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Spain Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Russia Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Netherlands Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Nordic Countries Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Asia-Pacific Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Hemocompatible Coatings Market Share by Country (2021-2032)
Figure 38. China Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Japan Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. South Korea Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. India Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India Hemocompatible Coatings Market Share by Country (2021-2032)
Figure 43. Australia Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. China Taiwan Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. South America Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America Hemocompatible Coatings Market Share by Country (2021-2032)
Figure 48. Brazil Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. Argentina Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Chile Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Colombia Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Peru Hemocompatible Coatings Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Surmodics Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 54. Carmeda AB Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 55. Coatings2Go Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 56. DSM Biomedical Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 57. Hydromer Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 58. AST Products Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 59. Smart Reactors Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 60. Alfa Chemistry Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 61. Biomerics Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 62. Jiangsu Biosurf Biotech Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 63. Corline Biomedical Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 64. BioInteractions Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 65. Aurorium Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 66. Alta Biomed Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
Figure 67. jMedtech Revenue Growth Rate in Hemocompatible Coatings Business (2021-2026)
提及公司
SurmodicsCarmeda ABCoatings2GoDSM BiomedicalHydromerAST ProductsSmart ReactorsAlfa ChemistryBiomericsJiangsu Biosurf BiotechCorline BiomedicalBioInteractionsAuroriumAlta BiomedjMedtech
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們